A detailed history of Amalgamated Bank transactions in Axonics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,747 shares of AXNX stock, worth $124,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,747
Previous 1,747 -0.0%
Holding current value
$124,002
Previous $117,000 4.27%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$66.47 - $69.65 $4,586 - $4,805
69 Added 4.11%
1,747 $117,000
Q1 2024

Apr 23, 2024

SELL
$56.67 - $69.36 $304,544 - $372,740
-5,374 Reduced 76.21%
1,678 $116,000
Q4 2023

Feb 06, 2024

SELL
$49.38 - $63.75 $24,640 - $31,811
-499 Reduced 6.61%
7,052 $439,000
Q3 2023

Nov 08, 2023

BUY
$48.64 - $62.51 $3,988 - $5,125
82 Added 1.1%
7,551 $424,000
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $27,162 - $34,078
566 Added 8.2%
7,469 $376,000
Q1 2023

May 02, 2023

SELL
$52.6 - $67.34 $60,858 - $77,912
-1,157 Reduced 14.35%
6,903 $377,000
Q4 2022

Feb 10, 2023

BUY
$59.56 - $76.6 $7,683 - $9,881
129 Added 1.63%
8,060 $504,000
Q3 2022

Nov 09, 2022

BUY
$57.96 - $78.12 $28,516 - $38,435
492 Added 6.61%
7,931 $559,000
Q2 2022

Aug 15, 2022

SELL
$39.5 - $64.42 $2,488 - $4,058
-63 Reduced 0.84%
7,439 $422,000
Q1 2022

Jun 30, 2022

SELL
$43.74 - $62.76 $24,625 - $35,333
-563 Reduced 6.98%
7,502 $470,000
Q4 2021

Feb 15, 2022

SELL
$50.01 - $73.35 $4,000 - $5,868
-80 Reduced 0.98%
8,065 $452,000
Q3 2021

Oct 29, 2021

BUY
$59.21 - $78.66 $16,815 - $22,339
284 Added 3.61%
8,145 $530,000
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $183,051 - $238,297
3,562 Added 82.86%
7,861 $498,000
Q1 2021

May 13, 2021

SELL
$49.14 - $59.89 $21,031 - $25,632
-428 Reduced 9.05%
4,299 $257,000
Q4 2020

Feb 12, 2021

BUY
$42.19 - $51.5 $928 - $1,133
22 Added 0.47%
4,727 $235,000
Q3 2020

Oct 30, 2020

BUY
$35.33 - $51.04 $166,227 - $240,143
4,705 New
4,705 $240,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.